Trials / Completed
CompletedNCT05280769
Effects of an Oral Nicotine Product in Smokeless Tobacco Users
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research study is to find out how three different nicotine pouches and participant's own brand of smokeless tobacco affect blood nicotine levels and how participants feel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | oral nicotine pouch - 2 mg | "On" brand oral nicotine pouch with 2 mg of protonated nicotine in "original" flavor |
| OTHER | oral nicotine pouch - 4 mg | "On" brand oral nicotine pouch with 4 mg of protonated nicotine in "original" flavor |
| OTHER | oral nicotine pouch - 8 mg | "On" brand oral nicotine pouch with 8 mg of protonated nicotine in "original" flavor |
| OTHER | Smokeless tobacco | Participant's typical brand of smokeless tobacco |
Timeline
- Start date
- 2022-08-23
- Primary completion
- 2023-11-28
- Completion
- 2023-11-28
- First posted
- 2022-03-15
- Last updated
- 2024-10-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05280769. Inclusion in this directory is not an endorsement.